Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies
▪ Abstract As many more clinical trials collect economic information within their study design,
so health economics analysts are increasingly working with patient-level data on both costs …
so health economics analysts are increasingly working with patient-level data on both costs …
Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies
DA Revicki, L Frank - Pharmacoeconomics, 1999 - Springer
Pharmacoeconomic data may be obtained within the context of randomised clinical trials
(RCTs) and from effectiveness studies in the 'real world'. The differences between the 2 …
(RCTs) and from effectiveness studies in the 'real world'. The differences between the 2 …
[کتاب][B] Applied methods of cost-effectiveness analysis in healthcare
AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth - 2010 - books.google.com
The third volume in the Handbooks in Health Economic Evaluation series, this book
provides the reader with a comprehensive set of instructions and examples of how to …
provides the reader with a comprehensive set of instructions and examples of how to …
[کتاب][B] Economic evaluation in clinical trials
It is becoming increasingly important to examine the relationship between the outcomes of a
clinical trial and the costs of the medical therapy under study. The results of such analysis …
clinical trial and the costs of the medical therapy under study. The results of such analysis …
Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility
In trial‐based cost‐effectiveness analysis baseline mean utility values are invariably
imbalanced between treatment arms. A patient's baseline utility is likely to be highly …
imbalanced between treatment arms. A patient's baseline utility is likely to be highly …
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
Economic evaluation is often seen as a branch of health economics divorced from
mainstream econometric techniques. Instead, it is perceived as relying on statistical methods …
mainstream econometric techniques. Instead, it is perceived as relying on statistical methods …
Calculating and interpreting ICERs and net benefit
M Paulden - Pharmacoeconomics, 2020 - Springer
For several decades, the incremental cost-effectiveness ratio has been routinely used by
health technology assessment agencies around the world to summarise the results of …
health technology assessment agencies around the world to summarise the results of …
Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data
The current interest in undertaking cost‐effectiveness analyses alongside clinical trials has
lead to the increasing availability of patient‐level data on both the costs and effectiveness of …
lead to the increasing availability of patient‐level data on both the costs and effectiveness of …
Confidence intervals or surfaces? Uncertainty on the cost‐effectiveness plane
Although cost‐effectiveness analysis is not new, it is only recently that economic analysis
has been conducted alongside clinical trials. Whereas in the past economic analysts most …
has been conducted alongside clinical trials. Whereas in the past economic analysts most …
Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Background Glaucoma, particularly primary angle closure glaucoma (PACG), is a leading
cause of global blindness. Nearly half of all people with PACG are of Chinese descent …
cause of global blindness. Nearly half of all people with PACG are of Chinese descent …